Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rifalazil in Carotid Atherosclerosis
NCT00385385Phase 2Unknown
- Sponsor
- ActivBiotics, Inc.
- Start
- Oct 2006
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of rifalazil in carotid atheroma (CAS), sponsored by ActivBiotics, Inc.. Status: unknown.
02
Drugs
rifalazil
03
Conditions
carotid atheroma (CAS)
Beyond the preview
Go deeper on NCT00385385.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00385385.